Glenmark Pharma Sends Annual Report Link to Shareholders

Glenmark Pharmaceuticals Ltd is sending letters to shareholders whose email addresses are not registered, providing a web link and QR code to access the Integrated Annual Report and AGM Notice for FY 2025-26. This communication is in compliance with SEBI Listing Regulations. The 48th Annual General Meeting is scheduled for September 11, 2026, to be held via Video Conference. Shareholders can opt for permanent email registration for future communications.